𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined chemotherapy and surgery in breast cancer: A review

✍ Scribed by Dr. Douglass C. Tormey

Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
960 KB
Volume
36
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Preoperative chemotherapy treatment of b
Preoperative chemotherapy treatment of breast cancerβ€”A review
✍ Aman U. Buzdar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 147 KB

## Abstract Despite proven benefits of neoadjuvant chemotherapy in patients with locally advanced, invasive breast cancer, no regimen is recommended as the treatment of choice. Neoadjuvant chemotherapy regimens encompass single‐agent and combination therapy and sequential treatment. For this report

Combination chemotherapy in the treatmen
Combination chemotherapy in the treatment of advanced breast cancer
✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.

Ten-year survival rates in breast cancer
Ten-year survival rates in breast cancer using combination chemotherapy
✍ Kathleen Hancock; B. Gadsby Peet; J. J. Price; G. Whyte Watson; Joan Stone; R. L πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 389 KB

## Abstract The outcome in 254 patients with all stages of breast cancer treated by combination chemotherapy is presented. All the patients were treated 10 ormore years ago. The 10-year survival rate for Stages, and II corrt bined is 60 per cent, in Stage III 19 per cent and in Stage IV 3 per cent.